Stay updated on MPS IIIB Enzyme Replacement Clinical Trial
Sign up to get notified when there's something new on the MPS IIIB Enzyme Replacement Clinical Trial page.

Latest updates to the MPS IIIB Enzyme Replacement Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedLocations section updated to include California as a study site; the California Locations entry was removed. The HHS Vulnerability Disclosure link in the footer was removed in this revision.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedThe changes are limited to metadata about publication listings and page revision notes, which do not alter the study content, eligibility criteria, or reported results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe notice about a lapse in government funding and the associated operating-status information has been removed.SummaryDifference0.4%

- Check68 days agoChange DetectedThe Study Details page layout has been updated with formatting changes, with no new data or eligibility adjustments.SummaryDifference0.4%

- Check97 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference3%

- Check104 days agoChange DetectedUpdate includes standardizing the disease name to Mucopolysaccharidosis type 3B and upgrading the revision from v3.0.2 to v3.1.0 (no new substantive content beyond terminology and versioning).SummaryDifference0.2%

Stay in the know with updates to MPS IIIB Enzyme Replacement Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MPS IIIB Enzyme Replacement Clinical Trial page.